Race to save kidneys in cancer patients: old vs. new treatments face off
NCT ID NCT06483139
Summary
This study aims to find the best treatment to help patients with multiple myeloma recover from severe kidney damage caused by the disease. It will compare three approaches: a blood-filtering procedure called plasma exchange, newer drug regimens based on daratumumab, and older drug combinations. The main goal is to see which treatment helps more patients survive and regain enough kidney function to stop needing dialysis within 90 days.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACUTE KIDNEY INJURY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Brigham and Women's Hospital
RECRUITINGBoston, Massachusetts, 02130, United States
Contact
Conditions
Explore the condition pages connected to this study.